Latest Manufacturing And Distribution News

Page 6 of 10
Algorae Pharmaceuticals has locked in a $3 million revolving debt facility with ScotPac, providing flexible, non-dilutive funding to accelerate its commercial operations across Australia and New Zealand.
Victor Sage
Victor Sage
21 Jan 2026
Fletcher Building has agreed to sell its Construction Division to global giant VINCI Construction for an initial $315.6 million, with potential to rise to $334.1 million. The move marks a strategic pivot towards focused building products manufacturing.
Victor Sage
Victor Sage
20 Jan 2026
Little Green Pharma Ltd has agreed to acquire Cannatrek Ltd in a transformational merger that will create a leading vertically integrated medicinal cannabis group across Australia and Europe. The deal combines cultivation, manufacturing, distribution, clinics, and digital health platforms under one roof, positioning the combined entity for accelerated growth.
Ada Torres
Ada Torres
14 Jan 2026
MNC reports a strong FY25 marked by operational expansion and financial strengthening, setting the stage for disciplined international growth and premium brand elevation.
Victor Sage
Victor Sage
28 Nov 2025
Altech Batteries has completed the final design of its next-generation Sodium Nickel Chloride UPS battery system, setting the stage for factory testing and trial deployments across the Netherlands. This milestone marks a significant step toward broader European commercialisation.
Victor Sage
Victor Sage
27 Nov 2025
Audeara Limited has achieved a key regulatory milestone with NMPA certification in China, paving the way for commercial launch of its hearing personalisation technology through a leading e-commerce brand. This approval supports the company’s strategy to generate scalable licensing revenue in a rapidly growing market.
Ada Torres
Ada Torres
27 Nov 2025
Argent BioPharma has locked in an A$11 million convertible financing facility to finalize its strategic acquisition of AusCann assets and accelerate its growth plans, including a potential US stock exchange listing.
Ada Torres
Ada Torres
17 Nov 2025
Bioxyne Limited is expanding its footprint with a new UK GMP-certified medicinal cannabis manufacturing site, backed by £850,000 in funding from South of Scotland Enterprise. This move positions the company to tap into the UK’s growing medicinal cannabis market, the second largest in Europe.
Ada Torres
Ada Torres
17 Nov 2025
Fletcher Building has completed the sale of its 13.4% stake in the Pūhoi to Warkworth toll road, marking its exit from public-private partnership investments and a renewed focus on core operations.
Nora Hopper
Nora Hopper
10 Nov 2025
Bioxyne Limited, through its subsidiary Breathe Life Sciences, has inked an exclusive deal to import, manufacture, and distribute Curaleaf’s Que Medical Inhalation Device in Australia, with a nationwide launch set for November 2025.
Ada Torres
Ada Torres
3 Nov 2025
ClearVue Technologies has secured a $4.6 million capital raise and signed major partnerships, setting the stage for commercialisation in 2026 with a robust $60 million project pipeline.
Sophie Babbage
Sophie Babbage
31 Oct 2025
EVE Health Group has taken significant strides in commercialising its women’s and men’s health products Dyspro™ and Libbo™, securing regulatory clearances, first patient prescriptions, and raising $1.1 million to support market expansion.
Ada Torres
Ada Torres
31 Oct 2025

Browse the archive

Full archive